Filing Details
- Accession Number:
- 0000950170-24-134261
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-06 18:51:46
- Reporting Period:
- 2024-12-06
- Accepted Time:
- 2024-12-06 18:51:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1991792 | Cg Oncology Inc. | CGON | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1235862 | E Leonard Post | C/O Cg Oncology, Inc. 400 Spectrum Center Drive, Suite 2040 Irvine CA 92618 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-12-06 | 1,000 | $0.60 | 1,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-06 | 750 | $34.40 | 250 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-12-06 | 250 | $34.98 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2024-12-06 | 1,000 | $0.00 | 1,000 | $0.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 134,077 | 2028-07-08 | No | 4 | M | Direct |
Footnotes
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $33.91 to $34.87. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $34.92 to $35.05. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Fully vested.
Billionaire Hedge Funds
